Malignant neoplasm of aortic body and other paraganglia
ICD-10 C75.5 is a billable code used to indicate a diagnosis of malignant neoplasm of aortic body and other paraganglia.
C75.5 refers to malignant tumors arising from the aortic body and other paraganglia, which are neuroendocrine tissues located near major blood vessels. These tumors can secrete catecholamines, leading to symptoms such as hypertension, palpitations, and anxiety. The aortic body, located at the aortic arch, plays a crucial role in monitoring blood oxygen levels and regulating cardiovascular responses. Malignant neoplasms in this area can disrupt normal hormone function, leading to significant metabolic disturbances. Diagnosis typically involves imaging studies, such as CT or MRI, and may require biopsy for histological confirmation. Treatment often includes surgical resection, and in some cases, chemotherapy or radiation therapy may be indicated. The prognosis varies based on tumor size, metastasis, and the patient's overall health. Accurate coding is essential for appropriate treatment planning and reimbursement.
Detailed pathology reports, imaging studies, and treatment plans.
Diagnosis and management of malignant paragangliomas, treatment planning for surgical intervention.
Ensure accurate staging and grading of tumors for appropriate coding.
Hormonal assay results, clinical symptoms related to catecholamine secretion.
Management of hypertension and other symptoms due to catecholamine-secreting tumors.
Documenting the endocrine effects of the tumor is crucial for accurate coding.
Used when lymph nodes are biopsied to assess for metastasis from a malignant paraganglioma.
Document the reason for biopsy and findings.
Oncology specialists should ensure accurate coding for the biopsy site.
Common symptoms include hypertension, palpitations, anxiety, and other signs of catecholamine excess due to the tumor's neuroendocrine activity.
